FDG PET/CT for early prediction of response to neoadjuvant therapy in HER2+breast cancer: validation in a multicentric population

被引：0
|
作者：
Tisserand, S. [1 ]
Kanoun, S. [1 ]
Blanc, J. [1 ]
Coudert, B. [1 ]
Berriolo-Riedinger, A. [1 ]
Cachin, F. [2 ]
Champion, L. [3 ]
Humbert, O. [4 ]
Salaun, P. [5 ]
Mognetti, T. [6 ]
Kerrou, K. [7 ]
机构：
[1] Ctr Georges Francois Leclerc, Dijon, France
[2] Ctr Jean Perrin, Clermont Ferrand, France
[3] Inst Curie, Paris, France
[4] Ctr Antoine Lacassagne, Nice, France
[5] CHU Morvan, Brest, France
[6] Ctr Leon Berard, Lyon, France
[7] Hop Tenon, Paris, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-009
引用
收藏
页码：S305 / S306
页数：2
相关论文
共 50 条
  • [21] 18F-FDG PET/CT Predicts Response to HER2-directed Neoadjuvant Therapy
    Diwanji, Devan
    Ray, Kimberly
    Hylton, Nola
    [J]. RADIOLOGY-IMAGING CANCER, 2021, 3 (05):
  • [22] Identification of biomarkers including 18FDG-PET/CT for early prediction of response to neoadjuvant chemotherapy in Triple Negative Breast Cancer
    Humbert, O.
    Riedinger, J.
    Charon-Barra, C.
    Berriolo-Riedinger, A.
    Desmoulins, I.
    Lorgis, V.
    Kanoun, S.
    Coutant, C.
    Fumoleau, P.
    Brunotte, F.
    Cochet, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S248 - S248
  • [23] Prediction of the histopathological response to neoadjuvant chemotherapy by F-18-FDG PET/CT in patients with breast cancer
    Taki, Junichi
    Inokuchi, Masafumi
    Wakabayashi, Hiroshi
    Inaki, Anri
    Nakamura, Ayane
    Mochizuki, Takafumi
    Kinuya, Seigo
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [24] 18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO
    Kenny, Laura M.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) : 1855 - 1856
  • [25] Identification of UGT2B15 as a potential biomarker in response to neoadjuvant therapy in HER2+breast cancer
    Gil-Torralvo, Ana
    Benavent, Marta
    Dominguez-Cejudo, Maria A.
    Falcon, Alejandro
    Vieites, Begona
    Molina-Pinela, Sonia
    Ruiz, Manuel
    Montano, Alvaro
    Gonzalez, Rosario
    Martinez, Julia
    de la Haba, Juan
    Rodriguez, Antonio
    Queipo, Maria I.
    Jimenez, Begona
    Salvador-Bofill, Javier
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [26] FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer
    Tokes, Timea
    Torgyik, Laszlo
    Kulka, Janina
    Borka, Katalin
    Szasz, Attila Marcell
    Toth, Andrea
    Harsanyi, Laszlo
    Lengyel, Zsolt
    Gyoerke, Tamas
    Dank, Magdolna
    [J]. CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (02): : 306 - 312
  • [27] 18F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer
    Ebinc, Senar
    Guzel, Yunus
    Oruc, Zeynep
    Komek, Halil
    Kalkan, Ziya
    Can, Canan
    Tasdemir, Bekir
    Urakci, Zuhat
    Kaplan, Muhammet Ali
    Kucukoner, Mehmet
    Isikdogan, Abdurrahman
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (01) : 81 - 90
  • [28] Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
    Keam, Bhumsuk
    Im, Seock-Ah
    Koh, Youngil
    Han, Sae-Won
    Oh, Do-Youn
    Cho, Nariya
    Kim, Jee Hyun
    Han, Wonshik
    Kang, Keon Wook
    Moon, Woo Kyung
    Kim, Tae-You
    Park, In Ae
    Noh, Dong-Young
    Chung, June-Key
    Bang, Yung-Jue
    [J]. BMC CANCER, 2011, 11
  • [29] Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
    Bhumsuk Keam
    Seock-Ah Im
    Youngil Koh
    Sae-Won Han
    Do-Youn Oh
    Nariya Cho
    Jee Hyun Kim
    Wonshik Han
    Keon Wook Kang
    Woo Kyung Moon
    Tae-You Kim
    In Ae Park
    Dong-Young Noh
    June-Key Chung
    Yung-Jue Bang
    [J]. BMC Cancer, 11
  • [30] Early evaluation of response to neoadjuvant treatment: FDG-PET/CT criteria according to breast cancer subtype
    Groheux, David
    Majdoub, Mohamed
    de Cremoux, Patricia
    Hindie, Elif
    Martineau, Antoine
    Merlet, Pascal
    Visvikis, Dimitris
    Hatt, Mathieu
    Espie, Marc
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
12345